Physician profile
James R Valice
NPI 1437144482
$2,951.40
in general payments reported to CMS, 2019-2025
23 companies · $885 in 2025
The $885 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $152 · 2021: $246 · 2022: $396 · 2023: $415 · 2024: $601 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,021.51 | 2019-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $402.96 | 2022-2025 | Syfovre |
| Abbvie INC. | $273.13 | 2022-2025 | Ozurdex |
| Novartis Pharmaceuticals Corporation | $254.02 | 2019-2023 | |
| Genentech USA, INC. | $217.89 | 2022-2025 | Vabysmo |
| Alcon Vision LLC | $180.58 | 2019-2025 | Clareon Panoptix Pro, Rocklatan |
| Allergan, INC. | $136.15 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $70.02 | 2022-2023 | Miebo, Xipere |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.05 | 2019-2021 | |
| Harrow Eye, LLC | $49.90 | 2025 | Vevye |
| Amgen INC. | $48.32 | 2024 | Tepezza |
| Lombart Brothers, INC. | $30.65 | 2022 | |
| Biogen, INC. | $23.84 | 2022 | |
| Spark Therapeutics, INC. | $22.09 | 2020 | |
| Astellas Pharma US INC | $20.82 | 2024 | Izervay |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $20.78 | 2024 | Tecnis Iol |
| Dompe US, INC. | $20.69 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2021 | |
| Sight Sciences, INC. | $17.92 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Eyepoint US, INC. | $17.45 | 2023 | |
| Coopervision INC. | $16.89 | 2025 | Misight Contact Lens |
| Oyster Point Pharma, INC. | $16.72 | 2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $14.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Valice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.